Navigation Links
OTC sale for Xenical; Diet Drug; gets FDA approval

Prescription diet drug Xenical manufactured by GlaxoSmithkline got a nod for OTC sale from FDA.It received an "approvable" letter from the Food// and Drug Administration so that it can be marketed once the company addresses additional questions from regulators. An estimated arrival time for the sale is early next year.

It would become the first F.D.A.-approved weight-loss product sold without a doctor's prescription. The diet drug has been christened Alli.

A federal advisory panel voted 11 to 3 in January that the drug, which works by blocking fat absorption, could be sold without a prescription.

Although Xenical has been available as a prescription drug since 1999, it never got the star status partly because about half of the people who use it have episodes of diarrhoea, oily stools and flatulence because of fat that is excreted from the body rather than absorbed.

Clinical studies of the lower-dose over-the-counter version have shown that people using the drug lose more than their counterparts on similar diets who do not take the medication — an average of about five to six additional pounds more over six months. About 18 percent lose 10 percent or more of their initial body weight.

If it wins final approval, it would be the only FDA-endorsed weight-loss drug available without a prescription. But some experts express concern about people regaining weight after they stop using the drug, as well as whether people will be able to tell if it is safe for them without a doctor's advice. The drug can also lead to hepatitis, gallstones and kidney stones, although the exact cause is not clear.

But Gbola Amusa, an analyst in London for Sanford C. Bernstein & Company, said, "I'm assuming that the F.D.A. is addressing some things related to how they can ensure that this drug is not used inappropriately”.

So the diet pill Xenical would soon be seen in shops.


'"/>




Page: 1

Related medicine news :

1. Ranbaxy gets US FDA approval for Lisinopril
2. Aurobindo gets U.S. FDA approval for Cephalexin
3. Cadila gets US FDA approval for Promethazine tablets
4. Anti-obesity drugs for FDA approval
5. Grand FDA nod and approval for drug for heart transplant patients
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/9/2016)... ... 09, 2016 , ... Groth Family Insurance, a Washington-based firm ... initiating a charity drive to support the family of Cindy Hendrickson, a local ... , On October 29th of this year, Cindy Hendrickson swerved to avoid an ...
(Date:12/9/2016)... ... 09, 2016 , ... "I have gout, and I wanted to treat it ... is meant to relieve gout and pain caused by varicose veins. I drank it ... time. It relieved what VA doctors called the worst sinusitis case they'd seen and ...
(Date:12/9/2016)... ... 2016 , ... An inventor from Cana, Va., wanted to fulfill the need ... park rides. , The patent-pending SAFETY STRAP FOR AMPUTEES improves accessibility. It eliminates discrimination. ... set up in a matter of minutes, or even seconds. The SAFETY STRAP FOR ...
(Date:12/9/2016)... ... December 09, 2016 , ... MEDI+SIGN®, a provider of fully-automated ... new solution for Emergency Departments (ED) has been added to their portfolio. Housed ... examination rooms, and with a simplified pallet of information available to the patient, ...
(Date:12/8/2016)... ... 2016 , ... The West Virginia Medical Institute (WVMI) announced ... name change aligns the entire company with its existing Quality Insights branded projects ... are very proud of the achievements associated with the West Virginia Medical Institute ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... KEY FINDINGS The global medical ... Various reasons for growth of the medical lifting sling ... chronic diseases, high recovery cost of injuries and government ... lifting sling refers to an assistive device that helps ... connect to the lift and hold the patient. It ...
(Date:12/8/2016)... , Dec. 8, 2016  Eli Lilly and ... results of its phase 3 EXPEDITION3 trial at the ... meeting. As previously disclosed, solanezumab did not meet the ... of solanezumab initiated in people with mild dementia due ... regulatory submissions for solanezumab for the treatment of mild ...
(Date:12/8/2016)... 2016   TriNetX , the health research ... signed a membership agreement to join the ... new cures. The TriNetX network is ... patients globally, biopharmaceutical companies and contract research organizations ... design, site selection, patient recruitment, and collaborative research ...
Breaking Medicine Technology: